ArticleScientific reports2026
α-terpineol induces apoptosis in melanoma cells and its underlying mechanism.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated Chemical, Computational, and Cellular Profiling of a Dual-Oil Melanoma Formulation: An Exploratory Life-Science Study.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cutaneous melanoma is an aggressive skin cancer known for its ability to metastasize, resist treatment, and result in poor outcomes. With rising global incidence, early diagnosis and effective treatment strategies are imperative. Plant-derived extracts and natural compounds have emerged as promising therapeutic agents against various cancers, including melanoma. α-Terpineol, a volatile monoterpenoid alcohol found in pine needle oil and other essential oils, has demonstrated significant antitumor activity. We evaluated α-terpineol’s effects using scratch wound, Transwell, and colony formation assays to assess migration, invasion, and clonogenicity. Cell proliferation and apoptosis were examined via EdU and AO/EB staining, while flow cytometry analyzed cell cycle distribution and apoptosis rates. Potential targets were identified through network pharmacology and molecular docking, while Western blotting confirmed pathways related to apoptosis. A B16-F10 xenograft model was used to further validate in vivo efficacy. In vitro studies demonstrated that α-terpineol inhibits melanoma cell proliferation, migration, and invasion by triggering apoptosis. Network pharmacology identified the JAK2/STAT3 signaling pathway as crucial, with Western blot analysis showing reduced levels of p-JAK2 and p-STAT3. In vivo, α-terpineol inhibited tumor growth without causing systemic toxicity. α-Terpineol may attenuate melanoma progression by inhibiting JAK2/STAT3 signaling, highlighting its potential as a novel therapeutic candidate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.